Abstract
PurposeThe pathogenesis of age-related macular degeneration (AMD) involves aberrant complement activation and is a leading cause of vision loss worldwide. Complement aberrations are also implicated in many systemic immune-mediated inflammatory diseases (IMIDs), but the relationship between AMD and these conditions remains undescribed. The aim of this study is to first assess the association between AMD and IMIDs, and then assess the risk of AMD in patients with specific IMIDs associated with AMD. DesignCross-sectional study and cohort study Subjects and ControlsPatients with AMD were compared to control patients with cataracts and no AMD to ensure evaluation by an ophthalmologist. Patients with IMIDs were compared to patients without IMIDs but with cataracts. MethodsThis study used de-identified data from a national database (2006-2023), using ICD-10 codes to select for IMIDs. Propensity score matching was based on patients on age, sex, race, ethnicity, and smoking. Odds ratios were generated for IMIDs and compared between AMD and control patients. For IMIDs associated with AMD, the risk of AMD in patients with the IMID versus patients without IMIDs was determined utilizing a cohort study design. Main outcome measuresOdds ratio of IMID, risk ratios (RR) and 95% confidence intervals (CI) of AMD diagnosis given an IMID. ResultsAfter propensity-score matching, AMD and control cohorts (n = 217,197 each) had a mean age of 74.7+/- 10.4 years were 56% female and 9% of patients smoked. AMD showed associations with systemic lupus erythematosus (SLE), Crohn’s disease, ulcerative colitis (UC), rheumatoid arthritis, psoriasis, sarcoidosis, scleroderma, giant cell arteritis (GCA), and vasculitis. Cohorts for each positively associated IMID were created and matched to control cohorts with no IMID history. RA (RR 1.40, 95% CI 1.30-1.49), SLE (RR 1.73, 1.37-2.18), Crohn’s (RR 1.42, 1.20-1.71), UC (RR 1.45, 1.29-1.63), psoriasis (RR 1.48, 1.37-1.60), vasculitis (RR 1.48, 1.33-1.64), scleroderma (RR 1.65, 1.35-2.02), and sarcoidosis (RR 1.42, 1.24-1.62) showed a higher risk of developing AMD compared to controls. ConclusionThe results suggest that there is an increased risk of developing AMD in patients with RA, SLE, Crohn’s disease, UC, psoriasis, vasculitis, scleroderma, and sarcoidosis compared to patients with no IMIDs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
